Frequency and Prognostic Significance of Abnormal Liver Function Tests in Patients With Cardiogenic Shock
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F65269705%3A_____%2F17%3A00067450" target="_blank" >RIV/65269705:_____/17:00067450 - isvavai.cz</a>
Result on the web
<a href="https://ac.els-cdn.com/S0002914917311116/1-s2.0-S0002914917311116-main.pdf?_tid=43cc5390-de67-11e7-8468-00000aab0f6c&acdnat=1512992265_c68c59cf45930a44335aa48155808f23" target="_blank" >https://ac.els-cdn.com/S0002914917311116/1-s2.0-S0002914917311116-main.pdf?_tid=43cc5390-de67-11e7-8468-00000aab0f6c&acdnat=1512992265_c68c59cf45930a44335aa48155808f23</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.amjcard.2017.06.049" target="_blank" >10.1016/j.amjcard.2017.06.049</a>
Alternative languages
Result language
angličtina
Original language name
Frequency and Prognostic Significance of Abnormal Liver Function Tests in Patients With Cardiogenic Shock
Original language description
Cardiogenic shock (CS) is a cardiac emergency often leading to multiple organ failure and death. Assessing organ dysfunction and appropriate risk stratification are central for the optimal management of these patients. The purpose of this study was to assess the prevalence of abnormal liver function tests (LFTs), as well as early changes of LFTs and their impact on outcome in CS. We measured LFTs in 178 patients in CS from serial blood samples taken at 0 hours, 12 hours, and 24 hours. The associations of LFT abnormalities and their early changes with all-cause 90-day mortality were estimated using Fisher's exact test and Cox proportional hazards regression analysis. Baseline alanine aminotransferase (ALT) was abnormal in 58% of the patients, more frequently in nonsurvivors. Abnormalities in other LFTs analyzed (alkaline phosphatase, gamma-glutamyl transferase, and total bilirubin) were not associated with short-term mortality. An increase in ALT of >20% within 24 hours (AALT>+20%) was observed in 24% of patients. AALT>+20% was associated with a more than 2-fold increase in mortality compared with those with stable or decreasing ALT (70% and 28%, p <0.001). Multivariable regression analysis showed that AALT>+20% was associated with increased 90-day mortality independent of other known" risk factors. In conclusion, an increase in ALT in the initial phase was seen in 1/4 of patients in CS and was independently associated with 90-day mortality. This finding suggests that serial ALT measurements should be incorporated in the clinical assessment of patients in CS.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30201 - Cardiac and Cardiovascular systems
Result continuities
Project
—
Continuities
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Others
Publication year
2017
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
American Journal of Cardiology
ISSN
0002-9149
e-ISSN
—
Volume of the periodical
120
Issue of the periodical within the volume
7
Country of publishing house
US - UNITED STATES
Number of pages
8
Pages from-to
1090-1097
UT code for WoS article
000412626000008
EID of the result in the Scopus database
—